📰 Realtime Dynamix News
Page 2 - Realtime Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Realtime Dynamix. Real-time updates on events, politics, business and more.
February 28, 2023
/PRNewswire/ -- On February 16, The Lancet Neurology published the Phase 3 results of Pfizers zavegepant for the acute treatment of migraine. The CGRP...
February 17, 2023
/PRNewswire/ -- According to Biogens earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third...
February 9, 2023
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists perceptions and...
January 20, 2023
/PRNewswire/ -- With SGLT2 inhibitors increasingly becoming the standard of care for diabetic and non-diabetic CKD patients, the broader CKD treatment has...
December 21, 2022
/PRNewswire/ -- Spherix Global Insights, a leading provider of market research, business intelligence, and advisory services to the global life sciences...
December 9, 2022
/PRNewswire/ -- On September 9, 2022, BMS announced the FDA approval of Sotyktu for moderate-to-severe plaque psoriasis (PsO), making it the first selective...
December 7, 2022
/PRNewswire/ -- On October 28, 2022, the European Medicines Agencys (EMA) safety committee (PRAC) announced recommendations to minimize the risk of serious...
December 6, 2022
/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...
December 6, 2022
/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...
November 10, 2022
/PRNewswire/ -- Rheumatologists in the EU5 (France, Germany, Italy, Spain, and the United Kingdom) recognize a disconnect in the diagnosis and referral process...